These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 20664684)

  • 1. Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).
    Maestre A; Muskus C; Duque V; Agudelo O; Liu P; Takagi A; Ntumngia FB; Adams JH; Sim KL; Hoffman SL; Corradin G; Velez ID; Wang R
    PLoS One; 2010 Jul; 5(7):e11437. PubMed ID: 20664684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duffy antigen receptor for chemokine (DARC) polymorphisms and its involvement in acquisition of inhibitory anti-duffy binding protein II (DBPII) immunity.
    Souza-Silva FA; Torres LM; Santos-Alves JR; Tang ML; Sanchez BA; Sousa TN; Fontes CJ; Nogueira PA; Rocha RS; Brito CF; Adams JH; Kano FS; Carvalho LH
    PLoS One; 2014; 9(4):e93782. PubMed ID: 24710306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria.
    Kano FS; de Souza AM; de Menezes Torres L; Costa MA; Souza-Silva FA; Sanchez BAM; Fontes CJF; Soares IS; de Brito CFA; Carvalho LH; Sousa TN
    Sci Rep; 2018 Sep; 8(1):13851. PubMed ID: 30218021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants.
    Kano FS; Souza-Silva FA; Torres LM; Lima BA; Sousa TN; Alves JR; Rocha RS; Fontes CJ; Sanchez BA; Adams JH; Brito CF; Pires DE; Ascher DB; Sell AM; Carvalho LH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005177. PubMed ID: 27959918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
    Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
    PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria.
    King CL; Adams JH; Xianli J; Grimberg BT; McHenry AM; Greenberg LJ; Siddiqui A; Howes RE; da Silva-Nunes M; Ferreira MU; Zimmerman PA
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20113-8. PubMed ID: 22123959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast.
    Herrera S; Gómez A; Vera O; Vergara J; Valderrama-Aguirre A; Maestre A; Méndez F; Wang R; Chitnis CE; Yazdani SS; Arévalo-Herrera M
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):44-9. PubMed ID: 16291766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duffy antigen receptor for chemokines gene polymorphisms and malaria in Mangaluru, India.
    Gai PP; van Loon W; Siegert K; Wedam J; Kulkarni SS; Rasalkar R; Boloor A; Kumar A; Jain A; Mahabala C; Baliga S; Devi R; Shenoy D; Gai P; Mockenhaupt FP
    Malar J; 2019 Sep; 18(1):328. PubMed ID: 31551092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
    Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
    Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
    Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
    J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens.
    Wang R; Arevalo-Herrera M; Gardner MJ; Bonelo A; Carlton JM; Gomez A; Vera O; Soto L; Vergara J; Bidwell SL; Domingo A; Fraser CM; Herrera S
    Eur J Immunol; 2005 Jun; 35(6):1859-68. PubMed ID: 15864779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.
    Molina DM; Finney OC; Arevalo-Herrera M; Herrera S; Felgner PL; Gardner MJ; Liang X; Wang R
    Am J Trop Med Hyg; 2012 Sep; 87(3):460-9. PubMed ID: 22826492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
    Pandey JP; Morais CG; Fontes CJ; Braga EM
    Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax.
    Barbedo MB; Ricci R; Jimenez MC; Cunha MG; Yazdani SS; Chitnis CE; Rodrigues MM; Soares IS
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):335-9. PubMed ID: 17568939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.
    Gnidehou S; Mitran CJ; Arango E; Banman S; Mena A; Medawar E; Lima BAS; Doritchamou J; Rajwani J; Jin A; Gavina K; Ntumngia F; Duffy P; Narum D; Ndam NT; Nielsen MA; Salanti A; Kano FS; Carvalho LH; Adams JH; Maestre A; Good MF; Yanow SK
    J Infect Dis; 2019 Jan; 219(1):110-120. PubMed ID: 30534974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.